Inventor · disambiguated record
Dimitris Papoutsakis
Also filed as: PAPOUTSAKIS DIMITRIS
5 granted patents·7 pending applications·13 citations·filing 2005–2012
73Inventor score
Technology areasA61P
Top patents by PatentIndex Score
12 records- 0178US7723356B2Quinuclidine derivatives and their use as muscarinic m3 receptor antagonistsNOVARTIS AG·Filed 2005·Granted May 25, 2010·3 cites·8 claims
- 0276US8173634B2Polymorphic form of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylicLIU YUGANG·Filed 2009·Granted May 8, 2012·7 cites·7 claims
- 0376US7989494B2Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamideNOVARTIS AG·Filed 2007·Granted Aug 2, 2011·3 cites·42 claims
- 0456US2009197936A1Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamideNOVARTIS AG·Filed 2007·Application pending·0 cites
- 0554US2010093749A1CompoundsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 0648US2011112308A1Salts of N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamideNOVARTIS AG·Filed 2011·Application pending·0 cites
- 0746US2010286409A1Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamideNOVARTIS AG·Filed 2010·Application pending·0 cites
- 0845US8865897B2Crystal modifications-3-(1H-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ioneKARPINSKI PIOTR·Filed 2007·Granted Oct 21, 2014·0 cites·9 claims
- 0940US8084463B2Quinuclidine derivatives and their use as muscarinic M3 receptor antagonistsPRESS NEIL J·Filed 2010·Granted Dec 27, 2011·0 cites·7 claims
- 1038US2008221336A1Pparalpha/Gamma Agonists and Processes of PreparingGARRETT CHRISTINE E·Filed 2006·Application pending·0 cites
- 1138US2012053184A1Salts of 3-(1h-ind0l-3-yl)-4-[2-(4-methyl-piperazin-i-yl)-quinazolin-4-yl]-pyrrole-2, 5-di oneKARPINSKI PIOTR·Filed 2011·Application pending·0 cites
- 1237US2012122836A1Polymorphic form of 1-(4--2-ethyl-benzyl)-azetidine-3-carboxylicLIU YUGANG·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →